APREA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.2 USD | -2.80% |
|
-2.80% | +10.64% |
Chart calendar Aprea Therapeutics, Inc.
164b9c2da6.qeqLZRQYw3a3d5jJ-uMpXSF0sov3zsAng-tyDcd3VUg.0J7bA3BZ9gfPBfCcsqIaAkQ7y7LBuLNusYgkP6QgOQnKkN4qWHz1FfQx6w~e96d389631967bd66af20d62575bab3c
Upcoming events on Aprea Therapeutics, Inc.
Past events on Aprea Therapeutics, Inc.
| 10/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract Number:7121 |
| 10/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract Number: 7117 |
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract Number: CT196 |
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract Number: CT195 |
| 26/03/2024 11:45 | Q4 2023 Earnings Release |
| 01/02/2024 14:00 | DDR Inhibitors Summit |
| 09/11/2023 21:05 | Q3 2023 Earnings Release |
| 31/10/2023 15:00 | Investor Meeting - Key Opinion Leader |
| 14/10/2023 17:30 | AACR-NCI-EORTC International Conference - Abstract No:C034 |
| 14/10/2023 17:30 | AACR-NCI-EORTC International Conference - Abstract No:C147 |
| 11/09/2023 21:30 | H.C. Wainwright Global Investment Conference |
| 23/08/2023 14:00 | Annual General Meeting |
| 10/08/2023 12:30 | Q2 2023 Earnings Release |
| 21/06/2023 18:00 | Maxim Group Virtual Healthcare Conference |
| 05/06/2023 19:15 | BIO International Convention |
| 15/05/2023 21:05 | Q1 2023 Earnings Release |
| 19/04/2023 14:00 | American Association for Cancer Research Meeting - Poster No - ATRN-119/ATRN-W1051 |
| 30/03/2023 17:05 | Q4 2022 Earnings Release |
| 14/03/2023 14:00 | Oppenheimer Healthcare Conference |
| 26/01/2023 18:30 | DDR Inhibitors Summit |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,58 0,68 -14.15% | 0,20 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -113 -119 4.39% | -15,5 -15,6 0.87% | -20,5 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -113 -118 3.51% | -15,5 -16,0 3.14% | -19,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -113 -116 3.24% | -14,3 -14,9 4.29% | -18,9 |
|
Net income Million USD | Released Forecast Spread | -37,1 | -113 -116 3.13% | -14,3 -14,9 4.43% | -18,9 |
|
EPS USD | Released Forecast Spread | -34,8 | -68,0 -87,3 22.08% | -3,95 -3,46 -14.27% | -2,60 |
| Announcement Date | 15/03/22 | 30/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,25 0,00 - | 0,32 0,08 283.38% | 0,10 | 0,00 | 0,00 | 0,00 | 0,20 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -2,65 -7,80 65.97% | -4,62 -3,20 -44.44% | -3,65 -4,10 10.94% | -3,52 -4,10 14.11% | -3,67 -3,80 3.42% | -4,60 | -4,80 | -5,50 | -5,70 | |||
|
EBIT Million USD | Released Forecast Spread | -22,4 -7,88 -184.8% | -4,20 -8,81 52.34% | -2,65 -6,24 57.52% | -4,62 -4,50 -2.72% | -3,65 -5,09 28.19% | -3,52 -4,62 23.76% | -3,67 -4,36 15.78% | -4,35 | -4,54 | -4,92 | -5,11 | -5,49 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -98,3 -7,70 -1175.59% | -4,02 -8,62 53.32% | -2,44 -6,22 60.72% | -4,38 -3,10 -41.29% | -3,26 -5,07 35.76% | -3,20 -4,35 26.39% | -3,44 -4,07 15.35% | -4,30 | -4,60 | -5,20 | -5,30 | -5,56 |
|
Net income Million USD | Released Forecast Spread | -98,3 -7,64 -1186.61% | -4,02 -8,46 52.45% | -2,44 -6,20 60.63% | -4,38 -3,10 -41.29% | -3,26 -5,14 36.53% | -3,20 -4,35 26.39% | -3,44 -4,07 15.36% | -4,30 | -4,60 | -5,20 | -5,30 | -5,56 |
|
EPS USD | Released Forecast Spread | -86,8 -7,00 -1140% | -2,40 -1,80 -33.33% | -0,92 -3,22 71.43% | -1,34 -1,51 10.96% | -0,87 -1,38 36.96% | -0,86 -1,16 26.07% | -0,92 -0,77 -18.97% | -0,78 | -0,81 | -0,83 | -0,54 | -1,00 |
| Announcement Date | 11/08/22 | 09/11/22 | 30/03/23 | 15/05/23 | 10/08/23 | 09/11/23 | 26/03/24 | - | - | - | - | - |
| Today 21:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 11:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 11:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 12:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Aprea Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- APRE Stock
- Calendar Aprea Therapeutics, Inc.
